Immunogenicity Associated with Botulinum Toxin Treatment by Steven Bellows, Joseph Jankovic

Subjects: “…botulinum toxin…”
Get full text

Botulinum Toxin in Movement Disorders: An Update by Charenya Anandan, Joseph Jankovic

Subjects: “…botulinum toxin…”
Get full text

Botulinum Toxin for the Treatment of Hand Tremor by Nicki Niemann, Joseph Jankovic

Subjects: Get full text

Use of botulinum toxin in the management of dystonia in Parkinson’s disease by Charenya Anandan, Charenya Anandan, Joseph Jankovic

Subjects: Get full text

Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia by Juan Ramirez-Castaneda, Joseph Jankovic

Subjects: Get full text

Botulinum Neurotoxin Injections in Childhood Opisthotonus by Mariam Hull, Mered Parnes, Joseph Jankovic

Subjects: Get full text

Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. <i>Toxins</i> 2019, <i>11</i>, 491 by Steven Bellows, Joseph Jankovic

Get full text

Botulinum Neurotoxin Injections in Children with Self-Injurious Behaviors by Mariam Hull, Mered Parnes, Joseph Jankovic

Subjects: Get full text

Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX^®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis by Joseph Jankovic, Jean Carruthers, Markus Naumann, Patricia Ogilvie, Terry Boodhoo, Mayssa Attar, Swati Gupta, Ritu Singh, John Soliman, Irina Yushmanova, Mitchell F. Brin, Jie Shen

“…Though the formation of neutralizing antibodies (NAbs) during treatment with botulinum neurotoxin is rare, their presence may nonetheless affect the biological activity of botulinum toxin and negatively impact clinical response. …”
Get full text